Walleye Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Sell |
414,322
-90,535
| -18% | -$522K | 0.01% | 578 |
|
|
2025
Q1 | $3.33M | Sell |
504,857
-31,461
| -6% | -$208K | 0.02% | 473 |
|
|
2024
Q4 | $4.67M | Sell |
536,318
-35,047
| -6% | -$305K | 0.01% | 451 |
|
|
2024
Q3 | $11.2M | Buy |
571,365
+496,284
| +661% | +$9.7M | 0.02% | 239 |
|
|
2024
Q2 | $1.55M | Sell |
75,081
-8,171
| -10% | -$168K | ﹤0.01% | 921 |
|
|
2024
Q1 | $1.78M | Buy |
83,252
+37,710
| +83% | +$804K | ﹤0.01% | 813 |
|
|
2023
Q4 | $655K | Sell |
45,542
-219,351
| -83% | -$3.15M | ﹤0.01% | 1063 |
|
|
2023
Q3 | $2.42M | Buy |
264,893
+182,221
| +220% | +$1.66M | 0.01% | 594 |
|
|
2023
Q2 | $875K | Buy |
+82,672
| New | +$875K | ﹤0.01% | 791 |
|
|
2022
Q4 | – | Sell |
-268,074
| Closed | -$3.66M | – | 2393 |
|
|
2022
Q3 | $3.66M | Buy |
+268,074
| New | +$3.66M | 0.07% | 277 |
|
|
2021
Q3 | – | Sell |
-20,990
| Closed | -$438 | – | 1682 |
|
|
2021
Q2 | $438 | Buy |
+20,990
| New | +$438 | 0.01% | 790 |
|
|
2018
Q3 | $1.05M | Buy |
+59,932
| New | +$1.05M | 0.49% | 52 |
|